Bizjournals.com reports that Charles River Laboratories International has opened a new research facility in China. The company announced that the 60,000-square-foot building in Shanghai was open for business. An increasing amount of larger pharmaceutical companies and smaller drug development startups are outsourcing their early-stage research to China and other locations around the world. Charles River built its new facility in order to capture some of that business. Early-stage research often includes testing on animals. Charles River said the facility will be compliant with a number of regulatory agencies including the Association for Assessment and Accreditation of Laboratory Animal Care, the Canadian Council on Animal Care, China’s State Food and Drug Administration, the Organization for Economic Cooperation and Development and the U.S. Food and Drug Administration. The Shanghai operation will begin full operation in early 2009. Charles River’s China expansion is part of a joint venture signed in March 2007 with Shanghai BioExplorer Co., which provides preclinical services. Their effort is known as Charles River Preclinical Services Greater China, which is majority owned by Charles River.